- Home
- MLTX vs AMSC Comparison
MLTX vs AMSC Comparison
Compare MLTX & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MLTX | AMSC |
|---|---|---|
| Founded | 2021 | 1987 |
| Country | Switzerland | United States |
| Employees | N/A | 400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2020 | 2012 |
Fundamental Metrics
Financial Performance| Metric | MLTX | AMSC |
|---|---|---|
| Price | $11.62 | $29.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 1 |
| Target Price | $27.50 | ★ $52.00 |
| AVG Volume (30 Days) | ★ 1.6M | 622.2K |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1806.25 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $900,000.00 |
| Revenue This Year | N/A | $34.98 |
| Revenue Next Year | N/A | $21.38 |
| P/E Ratio | ★ N/A | $150.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.08 | $24.87 |
| 52 Week High | $23.29 | $70.49 |
Technical Indicators
Market Signals| Indicator | MLTX | AMSC |
|---|---|---|
| Relative Strength Index (RSI) | 29.25 | 46.41 |
| Support Level | $11.06 | $29.17 |
| Resistance Level | $19.24 | $33.73 |
| Average True Range (ATR) | 0.76 | 1.08 |
| MACD | 0.03 | 0.25 |
| Stochastic Oscillator | 7.81 | 43.18 |
Price Performance
Historical ComparisonAbout MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.